[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights

T Carvalho, F Krammer, A Iwasaki - Nature Reviews Immunology, 2021 - nature.com
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …

[PDF][PDF] COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management

R Ochani, A Asad, F Yasmin, S Shaikh, H Khalid… - Infez Med, 2021 - infezmed.it
SUMMARY majority of patients tend to have a mild illness, a minority of patients develop
severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly …

[PDF][PDF] Living guidance for clinical management of COVID-19: living guidance, 23 November 2021

World Health Organization - 2021 - apps.who.int
This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

[PDF][PDF] COVID-19 clinical management: living guidance, 25 January 2021

(‎ 2021 World Health Organization - 2021 - apps.who.int
The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

[HTML][HTML] Characteristics of SARS-CoV-2 and COVID-19

B Hu, H Guo, P Zhou, ZL Shi - Nature reviews microbiology, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute …

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment

CT Wu, PV Lidsky, Y Xiao, IT Lee, R Cheng… - Cell metabolism, 2021 - cell.com
Emerging evidence points toward an intricate relationship between the pandemic of
coronavirus disease 2019 (COVID-19) and diabetes. While preexisting diabetes is …

COVID-19 transmission, current treatment, and future therapeutic strategies

VS Salian, JA Wright, PT Vedell, S Nair… - Molecular …, 2021 - ACS Publications
At the stroke of the New Year 2020, COVID-19, a zoonotic disease that would turn into a
global pandemic, was identified in the Chinese city of Wuhan. Although unique in its …

Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis

P Malik, U Patel, D Mehta, N Patel, R Kelkar… - BMJ evidence-based …, 2021 - ebm.bmj.com
Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

J Zheng, LYR Wong, K Li, AK Verma, ME Ortiz… - Nature, 2021 - nature.com
The ongoing coronavirus disease 2019 (COVID-19) pandemic is associated with substantial
morbidity and mortality. Although much has been learned in the first few months of the …

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

A Varatharaj, N Thomas, MA Ellul, NWS Davies… - The Lancet …, 2020 - thelancet.com
Background Concerns regarding potential neurological complications of COVID-19 are
being increasingly reported, primarily in small series. Larger studies have been limited by …